IOVANCE BIOTHERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $0.00 per share as of 2017-12-31, per its 10-K filed 2018-03-12.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2019-02-28
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $0.00.
- 2017-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $6.10.
- 2017-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $6.40.
- 2017-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $6.46.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-12 | |
| 2017-09-30 | $6.10 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $6.40 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $6.46 10-Q · filed 2017-05-03 | |
| 2016-12-31 | $6.48 10-K · filed 2019-02-28 | |
| 2016-09-30 | $6.49 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $8.14 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $7.13 10-Q · filed 2016-05-09 | |
| 2015-12-31 | $6.96 10-K · filed 2019-02-28 | |
| 2015-09-30 | $6.56 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.90 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $6.20 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $7.04 10-K · filed 2018-03-12 | $6.20 10-Q · filed 2015-05-11 |
| 2013-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |